Travel health needs and medication self-management among travellers using GLP-1-based medicines: a netnographic study

Clicks: 3
ID: 339386
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #80 of 83 articles by views in international journal of travel medicine and global health

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Use of glucagon-like peptide-1 (GLP-1)-based medicines is expanding, while travel-specific evidence remains limited. Travellers must maintain treatment as transport, accommodation, food and daily routines change. This study explored travel-health needs, treatment workload, capacity and medication self-management in online accounts of planned and experienced travel. Methods A qualitative netnographic study examined 129 publicly accessible English-language discussions from Reddit, TripAdvisor and Mumsnet concerning current or recent GLP-1-based medicine use and actual or planned travel. Inductive coding identified reported actions, concerns and adaptations before the Cumulative Complexity Model guided a second interpretive stage. Cross-sectional comparison by travel status described differences in retrieved content, and sensitivity analysis excluded 20 compounded-tirzepatide records. Results Analysis identified four linked findings: travel-related treatment workload and continuity, practical capacity for medication management, medication self-management and travel adaptations, and a cross-sectional pattern by travel status. Planned/upcoming records contained information seeking in 41/62 (66%) and medication logistics in 35/62 (56%), whereas experienced/current records contained eating and activity adaptation in 45/53 (85%). Suitable storage, itinerary flexibility, prior treatment experience and reliable guidance supported medication management. Travellers either maintained treatment while adapting travel practices or described moving, delaying, reducing or interrupting a dose when treatment and itinerary demands conflicted. Conclusions GLP-1-based medicines add travel-specific dosing, storage, tolerability, hydration and eating demands to medication-management problems already recognised in travel medicine. Planned and experienced records emphasised different problems, but the groups involved different contributors and do not show within-person change. Pre-travel assessment should address medication and itinerary fit, with treatment changes reviewed by the prescribing clinician and practical travel requirements addressed through authoritative travel-service information. Product-specific prescribing information should inform storage and dosing discussions.
Reference Key
openalex_W7225732218 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal international journal of travel medicine and global health
Year 2026
DOI
10.1093/jtm/taag103
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.